Novel Innovation Of Drug Changing Mechanism Improvement Towards Delivery System Using Prodrugs : A Paradigm Shift In Cancer Treatment.

  • Unique Paper ID: 170487
  • PageNo: 1500-1510
  • Abstract:
  • Cancer treatment has traditionally relied on systemic chemotherapy, often resulting in significant toxicity and limited efficacy. The emergence of prodrugs and targeted delivery systems has revolutionized this approach, enabling the selective delivery of therapeutic agents to tumor sites. This review provides an in-depth analysis of prodrug design, synthesis, and delivery systems, highlighting their potential to improve cancer treatment outcomes. We also discuss the challenges associated with these approaches and future directions for research. Cancer remains a leading cause of mortality worldwide, necessitating the development of innovative therapeutic strategies. Prodrugs and targeted delivery systems have emerged as promising approaches to enhance the efficacy and reduce the toxicity of cancer treatments. This review provides a comprehensive overview of recent advances in prodrug design, synthesis, and delivery systems, including nanoparticles, liposomes, and conjugates. We discuss the challenges and opportunities associated with these approaches and highlight their potential to revolutionize cancer treatment.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{170487,
        author = {Dr. D. K Vir Sir and Mrs. Snehal Dhewale Mam and Mr. Pratik Sandip Raut and Mr. Amol Anil Pawar and Mr. Rohit Ramdas Kurund and Mr. Rutik Sheshrao Kondke},
        title = {Novel Innovation Of Drug Changing Mechanism Improvement Towards Delivery System Using Prodrugs : A Paradigm Shift In Cancer Treatment.},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {1500-1510},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170487},
        abstract = {Cancer treatment has traditionally relied on systemic chemotherapy, often resulting in significant toxicity and limited efficacy. The emergence of prodrugs and targeted delivery systems has revolutionized this approach, enabling the selective delivery of therapeutic agents to tumor sites. This review provides an in-depth analysis of prodrug design, synthesis, and delivery systems, highlighting their potential to improve cancer treatment outcomes. We also discuss the challenges associated with these approaches and future directions for research.  Cancer remains a leading cause of mortality worldwide, necessitating the development of innovative therapeutic strategies. Prodrugs and targeted delivery systems have emerged as promising approaches to enhance the efficacy and reduce the toxicity of cancer treatments. This review provides a comprehensive overview of recent advances in prodrug design, synthesis, and delivery systems, including nanoparticles, liposomes, and conjugates. We discuss the challenges and opportunities associated with these approaches and highlight their potential to revolutionize cancer treatment.},
        keywords = {Prodrugs, API, Pharmacodynamics-Kinetics, ADME.},
        month = {December},
        }

Cite This Article

Sir, D. D. K. V., & Mam, M. S. D., & Raut, M. P. S., & Pawar, M. A. A., & Kurund, M. R. R., & Kondke, M. R. S. (2024). Novel Innovation Of Drug Changing Mechanism Improvement Towards Delivery System Using Prodrugs : A Paradigm Shift In Cancer Treatment.. International Journal of Innovative Research in Technology (IJIRT), 11(7), 1500–1510.

Related Articles